Axsome Therapeutics, Inc. employees and revenue per employee

AXSM · Biotechnology · $6.80B market cap

Axsome Therapeutics, Inc. had 925 employees at the end of fiscal Dec 2025, up 35.4% from a year earlier. Revenue for the year was $638M, up 65.5% from a year earlier, or $690K per employee. Revenue and headcount both grew, and revenue grew faster.

Employees

925

+35.4% YoY

Revenue

$638M

+65.5% YoY

Revenue / employee

$690K

Peer median $457K

Rank in industry

43 of 110

Biotechnology

Open roles

104

112 per 1,000 staff

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2022
66881370'22'23'24'25Revenue 1276Staff 242

Hover a year for the numbers.

AXSM employees and revenue by fiscal year
Year endingEmployeesRevenuePer employeeStaff YoYRevenue YoY
Dec 2025925$638M$690K+35.4%+65.5%
Dec 2024683$386M$565K+25.3%+42.5%
Dec 2023545$271M$497K+42.3%+440.8%
Dec 2022383$50.0M$131K——

Open roles on its job board: 104 (112 per 1,000 staff, against its latest annual headcount), as of 2026-11-20. Tracked since 2026-10-03. No 90 day change yet.

Employees, last six fiscal years
383'22545'23683'24925'25
Revenue per employee, last six fiscal years
$131K'22$497K'23$565K'24$690K'25

Axsome Therapeutics, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

CompanyEmployeesRevenueRevenue / employeeShape
TGTX
TG Therapeutics, Inc.
399$616M$1.54MEfficient growth
MIRM
Mirum Pharmaceuticals, Inc.
369$521M$1.41MEfficient growth
ARWR
Arrowhead Pharmaceuticals, Inc.
711$829M$1.17MEfficient growth
ADMA
ADMA Biologics, Inc.
647$510M$789KLeaner
AXSM
Axsome Therapeutics, Inc.
925$638M$690KEfficient growth
BBIO
BridgeBio Pharma, Inc.
834$502M$602KEfficient growth
TXG
10x Genomics, Inc.
1,178$643M$546KLeaner
RARE
Ultragenyx Pharmaceutical Inc.
1,371$673M$491KEfficient growth
INSM
Insmed Incorporated
1,664$606M$364KEfficient growth
Every Healthcare company

Questions about Axsome Therapeutics, Inc.

How many employees does Axsome Therapeutics, Inc. have?
Axsome Therapeutics, Inc. reported 925 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 23, 2026. That is up 35.4% from a year earlier.
What is Axsome Therapeutics, Inc.'s revenue per employee?
Axsome Therapeutics, Inc. brought in $638M of revenue in fiscal Dec 2025, which is $690K per employee. That ranks 43 of 110 companies we track in Biotechnology, where the median is $457K.
Is Axsome Therapeutics, Inc. hiring?
Axsome Therapeutics, Inc.'s public job board listed 104 open roles on November 20, 2026, about 112 per 1,000 staff.
Where do these numbers come from?
Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

This page is the filings. The research is a membership.

On the first and third Friday of each month Outpick publishes one stock pick with the full case for owning it, adds it to a live portfolio you can audit, and writes a note when a position closes. A new account gets 21 days of the whole membership with no card, and nothing is charged when it ends.

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

Compare AXSM with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Source: employee counts and revenue as stated in Axsome Therapeutics, Inc.'s annual reports (Form 10-K), latest filed February 23, 2026. This is data, not a recommendation to buy or sell AXSM.